Riding the pepTIDE — The Daily Wire on Therapeutic Peptides

An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.

Topic Sections

  • Top Shots — The most significant peptide and longevity stories ranked by overall editorial score
  • Research Signals — High-credibility scientific findings from journals, preprints, and clinical sources
  • Healing & Recovery — Tissue repair, injury recovery, and gut healing peptides including BPC-157 and TB-500
  • Growth Hormone Wire — Growth hormone secretagogues, peptide stacks, and GH axis research including Ipamorelin, CJC-1295, and MK-677
  • Metabolic & GLP-1 — Metabolic health, insulin sensitivity, and GLP-1 receptor agonist research including semaglutide and tirzepatide
  • Cognitive / Nootropic — Peptides targeting brain function, memory, neuroprotection, and cognitive enhancement
  • Skin & Cosmetic — Skin repair, anti-aging, collagen synthesis, and cosmetic peptide research including GHK-Cu and matrixyl
  • Reddit Finds — Community-sourced discussions, self-experimentation reports, and protocol threads from peptide communities
  • Contrarian Takes — Alternative viewpoints, dissenting research, and perspectives that challenge mainstream peptide narratives
  • Skeptic's Corner — Hype debunking, low-evidence alerts, and critical analysis of overstated peptide claims

Browse by Filter

  • Newest — Latest peptide and longevity stories
  • Most Credible — Highest credibility-scored stories
  • Most Edgy — High-novelty, unconventional findings
  • Most Discussed — Trending community discussions
  • Most Actionable — Direct applicability to daily health protocols
  • Lowest Risk — Stories with strong evidence, low hype
  • Research Only — Peer-reviewed and preprint studies
  • Reddit Only — Community discussion and anecdote
  • GLP-1 / Metabolic — Semaglutide, tirzepatide, and metabolic peptides
  • Healing / Recovery — BPC-157, TB-500, and repair protocols

More

  • About Riding the pepTIDE
  • Health Disclaimer
  • Submit a Source
  • Contact

Thyroid Marker Rose After Two Months on Mounjaro — Anyone Else?

Someone on a forum noticed that after two months of taking Mounjaro, some of their blood tests improved but their TSH (thyroid-stimulating hormone) level rose from around 2 to about 4. They’re asking if others have seen the same and are worried about what might be causing the increase. Mounjaro is the brand name for tirzepatide, a newer drug used to treat type 2 diabetes and sometimes for weight loss. It’s a kind of medication called a receptor agonist, which means it acts like certain natural hormones in your body to change how you process sugar and manage appetite. Think of it as a messenger that tells your body to slow stomach emptying, increase feelings of fullness, and help regulate blood sugar. It’s not a thyroid drug; it’s meant to work on gut and metabolic hormones. The report here is just one person’s experience and not a controlled study. A TSH rise from 2 to 4 is a measurable change, but it’s still a relatively modest shift and can be seen for many reasons. Single patient reports can’t prove cause and effect. Clinical trials of tirzepatide looked mainly at blood sugar, weight, and safety, and thyroid effects haven’t been a major consistent signal the way they were with some older drugs. That said, some medications can affect thyroid tests indirectly by changing weight, illness status, or lab timing. Without more data—like whether free thyroid hormones changed, whether symptoms appeared, or repeated tests—this one person’s result is a signal worth checking but not proof the drug caused a thyroid problem. For a regular person, the practical takeaways are straightforward. If you’re on Mounjaro and your doctor orders labs, watch your numbers over time rather than overreacting to a single test. A TSH around 4 is slightly higher than many labs’ ideal range, and some doctors would recheck it or look at symptoms (fatigue, weight change, cold intolerance, constipation) before starting treatment. If you already have thyroid disease or take thyroid hormone, you should tell your prescriber before starting or changing drugs like tirzepatide. Caveats: this is an anecdote, not proof. TSH can fluctuate for many reasons—illness, stress, lab variability, or other medications. Side effects of tirzepatide commonly reported include nausea, diarrhea, and decreased appetite; significant thyroid disease hasn’t been definitively tied to it in large studies so far. If you have symptoms or if your TSH stays elevated on repeat testing, ask your clinician about checking free T4 (a direct thyroid hormone measure) and getting an endocrine (thyroid specialist) opinion. Never stop or change prescribed medication without talking to your doctor. Bottom line: A single rise in TSH after starting Mounjaro is worth watching and discussing with your clinician, but it doesn’t by itself prove the drug caused thyroid disease.

Source: r/Mounjaro

Read full story

Back to Riding the pepTIDE